Abstracts

The WCN 2019 abstract submission process is now open and closes on November 12, 2018. You will be notified about the outcome of your application by January 3, 2019.

IT IS MANDATORY FOR THE PRESENTING AUTHOR TO REGISTER TO THE CONGRESS BY JANUARY 31, 2019 in order to have the abstract published as described below and for poster/oral presentation.

For registration rates and discounts click HERE.

 

How to submit your abstract

• Submit your abstract online. You will receive confirmation of the abstract submission within two business days. If you submit your abstract on the deadline day and do not receive confirmation within 48 hours, email: [email protected].
• Abstracts should concern all aspects of nephrology, the treatment of renal disease or the scientific background to the study of the kidney. Check out the abstract categories below:
  Categories and topics
  Glomerulonephritis

  • Podocytes, mesangial cells and glomerular function
  • Primary glomerulonephritis
  • Secondary glomerular disease
  • Glomerulonephritis experimental
  • Glomerular disease pathology
  • Glomerulonephritis clinical

  End stage kidney disease

  • Epidemiology, outcomes and health services research in dialysis
  • Peritoneal dialysis
  • Haemodialysis and hemodiafiltration
  • Vascular access
  • Complications of dialysis
  • Bioethics, palliative care and quality of life in dialysis

  Transplantation

  • Transplant immunology, tolerance and organ matching
  • Clinical studies in kidney transplantation

  Cell biology and basic science

  • Genetics and epigenetics
  • Developmental biology and stem cells
  • Experimental models of kidney disease
  • Cell signalling, control and death, hormones, growth factors and cytokines
  • Inflammation, fibrosis, matrix biology and oxidative stress
  • Vascular biology and endothelial function

  Acute kidney injury (AKI)

  • Acute kidney injury experimental models and biomarkers
  • Acute kidney injury clinical, drugs, AKI-CKD continuum
  • Tubular function, acid-base and electrolyte abnormalities in kidney disease

  Chronic kidney disease (CKD 2-5)

  • Chronic kidney disease diagnosis, classification and progression
  • Epidemiology, outcomes and health service research in CKD
  • Complications of CKD

  Diabetic kidney disease

  • Diabetes and obesity clinical
  • Diabetic kidney disease experimental models and biomarkers
  • Diabetic kidney disease drugs and treatments

  Nephrology general

  • Diet and nutrition
  • Paediatric nephrology
  • Kidney in pregnancy and post-partum
  • Bone and mineral metabolism
  • Anaemia and iron management
  • Hypertension
  • Autoimmune disease
  • Infection
  • Vasculitis, thrombotic microangiopathy and complement
  • Tubulointerstitial kidney disease, kidney stones, urinary tract infection
  • Cystic kidney disease
  • ‘Onconephrology’, urinary tract malignancy and chemotherapy
  • ‘Green’ nephrology and environmental sustainability
  • Other extracorporeal therapies, devices, poisoning and other technology
  • Indigenous peoples
• Submitted abstracts MUST describe unpublished work, which is not already in press and which is not awaiting possible acceptance by any other society/event that publishes its proceedings.

• FURTHER INSTRUCTIONS FOR COMPLETING YOUR ONLINE ABSTRACT SUBMISSION:
  Please check your abstract carefully for typographical errors, misspellings, poor hyphenation, etc. They will be glaringly apparent in the published abstract.
  You are allowed to use 3,400 characters. Abstracts are structured (Introduction, Methods, Results, Conclusion). Tables, graphs and pictures may be included (tables and graphs do not contribute to the character count if inserted as image).
  

  

Please be aware: We are a paperless congress. Accepted abstracts will be published electronically in the searchable databases of the WCN 2019 and Kidney International Reports (an official journal of the International Society of Nephrology). A selection of approx. 20 abstracts will also be published (electronically) at the ISN Academy. No printed abstract book will be produced. IT IS MANDATORY FOR THE PRESENTING AUTHOR TO REGISTER TO THE CONGRESS BY JANUARY 31, 2019 in order to have the abstract published as described above and for poster/oral presentation. HANDLING FEE    A 40 USD nonrefundable handling fee will be charged per each abstract submitted. The handling fee must be paid at the time of submission by credit card (American Express, MasterCard, or Visa). Payment by bank transfer is not possible. Abstract handling fees are waived for submitters from Low Income Countries as defined by the World Bank. If the presenting author is unable to present the abstract, another co-author can take his/her place as long as he/she is duly registered to the congress. A letter from the presenting author informing about the change is requested and must be sent to the congress secretariat, email: [email protected] no later than January 31, 2019. If selected abstract presenters fail to register by January 31, 2019, no abstract will be published. There will also be no poster/oral presentation at the congress. Once you have submitted your abstract, you cannot withdraw or change your abstract. All copyrights are assigned to ISN. Each abstract will be considered for a poster or oral presentation session. However, only limited slots are available for oral presentations during WCN 2019.

 

Organ trafficking and tourism ethics compliance

We believe that scientific studies and clinical activities must be performed in keeping with the ethical principles delineated in the Declaration of Istanbul on Organ Trafficking and Transplant Tourism.

By submitting an abstract for the WCN 2019, you state that you have not violated any aspect of the following:

• The Declaration of Istanbul on Organ Trafficking and Transplant Tourism Lancet. 2008 Jul 5;372 (9632):5-6.
  
• For Live Kidney Donation - The Consensus Statement of the Amsterdam Forum (Transplantation 79(6): S53-S66, 2005).
  
• For Live Donation of Extrarenal Organs - The Consensus Statement of the Vancouver Forum (Transplantation 81(4): 1373-1385, 2006).
  
• For Studies of Xenotransplantation - The International Xenotransplantation Association Ethics Committee Position Paper on The Ethics of Xenotransplantation (Xenotransplantation 10:194-203, 2003).
• For research involving human subjects - The Helsinki Declaration of The World Medical Association.
  
• The Ethical Statements of the Transplantation Society, TTS Ethics Policy.
  
• The TTS Ethics China.
• The Ethical Statements of the International Xenotransplantation Association.